All lobbying filings

WILLIAMS AND JENSEN, PLLC

Lobbying for NOVO NORDISK INC. · Pharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income · posted Oct 20, 2025

Official filing document

Bills named in this filing 1

HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 5

Health Issues

Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs.

Budget/Appropriations

Support for obesity drug coverage and access.

Medicare/Medicaid

Treat and Reduce Obesity Act; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN.

Taxation/Internal Revenue Code

Issues related to corporate tax and international tax including related domestic and international tax issues considered for reconciliation legislation and H.R. 1, One Big Beautiful Bill Act".

General issues related to patent protections.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.